Manipal Health Enterprises has filed its draft offer document with SEBI for an intial public offering (IPO), proposing to issue new equity shares worth Rs 8,000 crore along with an offer for sale (OFS) of up to 43.2 million shares.
The company plans to utilise Rs 5,478 crore from the fresh issue proceeds to repay borrowings, while Rs 574 crore will be used for the acquisition of a minority stake in its stepdown unit Sahyadri Hospitals and for general corporate purposes. Additionally, Manipal may consider a pre-IPO placement of up to Rs 1,600 crore, which, if completed, will reduce the size of the fresh issue.
Manipal Health Enterprises operates a pan-India network of multispecialty hospitals, covering cardiology, oncology, neurosurgery, gastrointestinal science, Orthopedics, liver transplantation surgery and kidney transplant, among others.
It operated 38 hospitals with 10,761 licensed beds across 14 states and union territories as of September 30, 2025. The company served 3.94 million patients in the six months ended September 30, 2025, and 7.19 million patients in FY2025. On the financial front, the company’s revenue from operations stood at Rs 8,242.2 crore, with a net profit of Rs 1,081.6 crore during FY25.
When a company’s shares are listed on a stock exchange, they become available for public trading. This allows the company to raise capital from a wide range of investors. Once listed, the shares can be bought and sold on the stock exchange, providing liquidity to investors and potentially increasing the company’s visibility and credibility.
To list themselves on the stock market, companies issue an Initial Public Offering (IPO), which requires compliance with Securities and Exchange Board of India (SEBI) norms.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money-related decisions.)
